Key result
Early discharge after TAVR was associated with a similar rate of 90-day readmission for permanent pacemaker implantation compared with late discharge (2.0% vs 1.8%; adjusted OR 1.15; P=0.15).
Why the study?
Despite a trend toward early discharge after TAVR, data were limited regarding its impact on readmissions for permanent pacemaker implantation.
Does early discharge after TAVR increase 90-day readmission for permanent pacemaker implantation compared to late discharge?
Cohort (n=68,482)
Yes
Does early discharge after TAVR increase 90-day readmission for permanent pacemaker implantation compared to late discharge?
Odds Ratio: 1.15 (95% CI 0.95–1.39)
Absolute Event Rate: 2% vs 1.8%
p-value: p=0.15
Early discharge after TAVR is safe and not associated with an increased risk of 90-day readmission for permanent pacemaker implantation compared to late discharge, while significantly lowering hospitalization costs.
Early TAVR discharge was associated with similar 90-day PPM readmission; leaves open randomized confirmation before practice change.
Objective To examine the rate of readmission for permanent pacemaker (PPM) implantation with early versus late discharge after transcatheter aortic valve replacement (TAVR). Background There is a current trend toward early discharge after TAVR. However, paucity of data exists on the impact of such practice on readmissions for PPM implantation. Methods The Nationwide Readmission Database 2016–2018 was queried for all hospitalizations where patients underwent TAVR. Hospitalizations were stratified into early (Days 0 and 1) versus late (≥Day 2) discharge groups. Observations in which PPM was required in the index admission were excluded. Multivariable regression analyses involving patient‐ and hospital‐related variables were utilized. The primary outcome was 90‐day readmission for PPM implantation. Results The final analysis included 68,482 TAVR hospitalizations, 20,261 (29.6%) with early versus 48,221 (70.4%) with late discharge. Early discharge after TAVR increased over the study period (16.2% in 2016 vs. 37.9% in 2018, P trend < 0.01). Nevertheless, 90‐day readmission for PPM implantation remained stable (1.8% in 2016 vs. 2.0% in 2018, P trend = 0.32). The 90‐day readmission rate for PPM implantation (2.0% vs. 1.8%; adjusted odds ratio: 1.15; 95% confidence interval: 0.95–1.39; p = 0.15) and median time‐to‐readmission (5 days [interquartile range, IQR 3–9] vs. 5 days [IQR 3–14], p = 0.92) were similar with early versus late discharge. Similar rates were observed regardless of whether readmission was elective versus not. Early discharge was associated with lower hospitalization cost ($39,990 ± $13,681 vs. $46,750 ± $18,218, p < 0.01) compared with late discharge. Conclusion In patients who did not require PPM during the index TAVR hospitalization, the rate of readmission for PPM implantation was similar with early versus late discharge.
No takes yet. Share an insight, caveat, or question.
Elzanaty et al. (2022) conducted a cohort in Transcatheter aortic valve replacement (TAVR) (n=68,482). Early discharge (Days 0 and 1) vs. Late discharge (≥Day 2) was evaluated on 90-day readmission for permanent pacemaker (PPM) implantation (adjusted OR 1.15, 95% CI 0.95-1.39, p=0.15). Early discharge after TAVR was associated with a similar rate of 90-day readmission for permanent pacemaker implantation compared with late discharge (2.0% vs 1.8%; adjusted OR 1.15; P=0.15).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: